Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Orencia approved for active polyarticular JIA in Japan

Feb. 26, 2018

Phase II development of LY-3337641 for rheumatoid arthritis ended

Feb. 20, 2018

Bristol-Myers Squibb identifies novel Toll-like receptor 7/8/9 antagonists

Feb. 19, 2018

RCGD-423 prevents articular cartilage degeneration and promotes repair in vivo

Feb. 19, 2018

Novartis studies LRX-712 in patients with osteoarthritis

Feb. 15, 2018

EMA grants ATMP classification to Regeneus' Progenza

Feb. 15, 2018

Therachon starts first-in-human trial of TA-46 for achondroplasia

Feb. 15, 2018

Phase III trials of peficitinib in rheumatoid arthritis meet primary endpoints

Feb. 9, 2018

Symic Biomedical reports MODIFY2 phase II trial results of SB-061 for knee osteoarthritis

Feb. 8, 2018

YL Biologics reports successful completion of phase III trial of etanercept biosimilar YLB-113

Feb. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...